Ascendis Closes First Round

Ascendis Pharma A/S, a privately held biotech company in Copenhagen Denmark, has closed its first-round of venture capital financing and the acquisition of Complex Biosystems GmbH. The series A financing of EUR 17.6 million was led by Sofinnova Partners (France) and co-led by Gilde Healthcare Partners (The Netherlands), with participation by Zweite TechnoStart Ventures Fonds GmbH & Co. KG (Germany).